id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-0307-0009,FDA,FDA-2012-D-0307,References List - Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products,Supporting & Related Material,Background Material,2016-01-15T05:00:00Z,2016,1,,,2016-01-15T16:03:51Z,,0,0,0900006481e0d8a6
FDA-2012-D-0307-0008,FDA,FDA-2012-D-0307,Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry,Other,Guidance,2016-01-14T05:00:00Z,2016,1,2016-01-14T05:00:00Z,,2024-11-11T21:21:28Z,,1,0,0900006481e0dc4c
FDA-2012-D-0307-0007,FDA,FDA-2012-D-0307,"Revised Preventive Measures To Reduce the Possible Risk of
Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob
Disease by Blood and Blood Products; Guidance for Industry; Availability",Notice,Notice of Availability,2016-01-14T05:00:00Z,2016,1,2016-01-14T05:00:00Z,,2016-01-14T15:19:15Z,2016-00536,0,0,0900006481e0d2aa